Andrea S. Blevins Primeau, PhD, MBA

Cancer patients with type 2 diabetes may have worse survival outcomes on immune checkpoint inhibitor therapy, a new study suggests.

Many patients with advanced neuroendocrine tumors may value preserving their quality of life over extending their survival, a small study suggests.

The Breast Cancer Index can predict benefit from ovarian function suppression in premenopausal patients with HR+, early-stage breast cancer.

Hypofractionated radiotherapy produces similar long-term outcomes as conventionally fractionated radiotherapy in high-risk prostate cancer, a phase 3 study suggests.

Individuals who are overweight or obese, or who become overweight or obese over time, have a higher risk of liver cancer and biliary tract cancer.

Many thyroid cancers are discovered in patients who undergo surgery without thyroid-referable symptoms, an international study suggests.

Adherence to the 2015 recommendation from ATA — to use lobectomy rather than complete thyroidectomy for low-risk differentiated thyroid cancer — is increasing.

Most imaging centers in the United States fail to analyze lateral neck lymph nodes during preoperative ultrasounds in patients with thyroid cancer.

Outcomes after radioiodine therapy are similar after preparation with either recombinant human thyrotropin or thyroid hormone withdrawal.

Nearly 800 women took cholesterol lowering medications during endocrine therapy and experienced a reduced risk of breast cancer recurrence.